High rate of fistula placement in a cohort of dialysis patients in a single payer system

Hemodialysis International

Volumn 14, Issue 4, 2010, Pages 393-397

  Blosser, Christopher D ^a   Ayehu, Gashu ^a   Wu, Sam ^a   Lomagro, Ruth M ^b   Malone, Ellen ^c   Brunelli, Steven M ^d   Itkin, Max ^c   Golden, Michael ^c   Mccombs, Peter ^c   Lipschutz, Joshua H ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Department of Medicine ^*  (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Fistula; Health care economics; Hemodialysis

Indexed keywords

ADULT; AGED; ARTERIOVENOUS FISTULA; ARTICLE; BLOOD VESSEL GRAFT; DEMOGRAPHY; FEMALE; HEALTH CARE COST; HEALTH CARE SYSTEM; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PATIENT CARE; PUBLIC HOSPITAL; REIMBURSEMENT; SINGLE PAYER SYSTEM; UNITED STATES; VASCULAR ACCESS;

AGED; ARTERIOVENOUS SHUNT, SURGICAL; CATHETERS, INDWELLING; COHORT STUDIES; COST-BENEFIT ANALYSIS; HOSPITALS, VETERANS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PHILADELPHIA; RENAL DIALYSIS; SINGLE-PAYER SYSTEM;

EID: 77958587305     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2010.00479.x     Document Type: Article

References (25)

1. Pastan S, Soucie JM, McClellan WM. Vascular access and increased risk of death among hemodialysis patients. Kidney Int. 2002; 62:620-626.
2. USRDS. Annual Data Report-2008. Available from (accessed January 24, 2010).
3. Lee H, Manns B, Taub K, et al. Cost analysis of ongoing care of patients with end-stage renal disease: The impact of dialysis modality and dialysis access. Am J Kidney Dis. 2002; 40:611-622.
4. Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK. Type of vascular access and mortality in US hemodialysis patients. Kidney Int. 2001; 60:1443-1451.
5. Pisoni RL, Young EW, Dykstra DM, et al. Vascular access use in Europe and the United States: Results from the DOPPS. Kidney Int. 2002; 61:305-316.
6. National Kidney Foundation. NKF-K/DOQI Clinical Practice guidelines for vascular access: National Kidney Foundation-Dialysis Outcomes Quality Initiative. Am J Kidney Dis. 1997; 30 (Suppl 3):S150-S191.
7. 2009 Medicare Physician's Fee Schedule-Pennsylvania Locality 01. Available from (accessed January 24, 2010).
8. Allon M., Robbin ML. Increasing arteriovenous fistulas in hemodialysis patients: Problems and solutions. Kidney Int. 2002; 62:1109-1124.
9. Centers for Medicare and Medicaid, Fistula First Breakthrough. Available at (accessed January 24, 2010).
10. Bittl JA, Cohen DJ, Seek MM, Feldman RL. Economic analysis of angiography and preemptive angioplasty to prevent hemodialysis-access thrombosis. Catheter Cardiovasc Interv. 2010; 75:14-21.
11. National Kidney Foundation. NKF-K/DOQI clinical practice guidelines for vascular access: Update 2006. Am J Kidney Dis. 2006; 48 (Suppl 1):S176-S276.
12. USRDS 2008. ADR Volume Two End-Stage Renal Disease. Available at (accessed February 26, 2010).
13. Pisoni RL, Arrington CJ, Albert JM, et al. Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: An instrumental variable analysis. Am J Kidney Dis. 2009; 539:475-491.
14. Chemla ES, Morsy MA. Is basilic vein transposition a real alternative to an arteriovenous bypass graft? A prospective study. Semin Dial. 2008; 21:352-356.
15. Moossavi S, Tuttle AB, Vachharajani TJ, et al. Long-term outcomes of transposed basilic vein arteriovenous fistulae. Hemodial Int. 2008; 12:80-84.
16. Woo K, Farber A, Doros G, Killeen K, Kohanzadeh S. Evaluation of the efficacy of the transposed upper arm arteriovenous fistula: A single institutional review of 190 basilic and cephalic vein transposition procedures. J Vasc Surg. 2007; 46:94-99.
17. Wolford HY, Hsu J, Rhodes JM, et al. Outcome after autogenous brachial-basilic upper-arm transposition in the post-National Kidney Foundation Dialysis Outcomes Quality Initiative era. J Vasc Surg. 2005; 42:951-956.
18. Beasley C, Nolan K, Steinfield RThe Vascular Access Working Group. National Vascular Access Improvement Initiative (NVAII). Boston, MA: Institute for Healthcare Improvement; 2003. Available at (accessed July 18, 2009).
19. Flu H, Breslau PJ, Krol-van Straaten JM, Hamming JF, Lardenoye JW. The effect of implantation of an optimized care protocol on the outcome of arteriovenous hemodialysis access surgery. J Vasc Surg. 2008; 48:659-668.
20. Fitzgerald JT, Schanzer A, Chin AI, McVicar JP, Perez RV, Troppmann C. Outcomes of upper arm arteriovenous fistulas for maintenance hemodialysis access. Arch Surg. 2004; 139:201-208.
21. Murphy GJ, Saunders R, Metcalfe M, Nicholson ML. Elbow fistulas using autogeneous vein: Patency rates and results of revision. Postgrad Med J. 2002; 78:483-486.
22. Hakaim AG, Nalbandian M, Scott T. Superior maturation and patency of primary brachiocephalic and transposed basilic vein arteriovenous fistulae in patients with diabetes. J Vasc Surg. 1998; 27:154-157.
23. Lin SL, Huang CH, Chen HS, Hsu WA, Yen CJ, Yen TS. Effects of age and diabetes on blood flow rate and primary outcome of newly created hemodialysis arteriovenous fistulas. Am J Nephrol. 1998; 18:96-100.
24. Dixon BS, Novak L, Fangman J. Hemodialysis vascular access survival: Upper-arm native arteriovenous fistula. Am J Kidney Dis. 2002; 39:92-101.
25. O'Hare AM, Dudley RA, Hynes DM, et al. Impact of surgeon and surgical center characteristics on choice of permanent vascular access. Kidney Int. 2003; 64:681-689.